Successful management of post-COVID-19 acanthamoebic encephalitis

Successful management of post-COVID-19 acanthamoebic encephalitis

Acanthamoebic encephalitis is a rare and highly fatal disease that has no standard management protocol. Coronavirus disease 2019 (COVID-19) causes immune dysfunction and may predispose patients to this infection.The present study describes successful management of acanthamoebic encephalitis in a you...

Full description

Bibliographic Details
Main Authors:	Govinda Siripurapu, Sameer Abdul Samad, Saman Fatima, Naveet Wig, M.V. Padma Srivastava
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	International Journal of Infectious Diseases
Subjects:	Acanthamoeba acanthamoebic encephalitis miltefosine COVID-19
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971221006020

Similar Items

Lethal outcome of granulomatous acanthamoebic encephalitis in a man who was human immunodeficiency virus-positive: a case report
by: Stefanie Geith, et al.
Published: (2018-07-01)

Successful Treatment of Disseminated Acanthamoeba sp. Infection with Miltefosine
by: Alexander C. Aichelburg, et al.
Published: (2008-11-01)

Acanthamoeba encephalitis in immunocompetent hosts: A report of two cases
by: Sohini Das, et al.
Published: (2020-01-01)

Clinical Improvement of Disseminated Acanthamoeba Infection in a Patient with Advanced HIV Using a Non-Miltefosine-Based Treatment Regimen in a Low-Resource Setting
by: Denasha L. Reddy, et al.
Published: (2022-02-01)

Topical Sustained Delivery of Miltefosine Via Drug-Eluting Contact Lenses to Treat Acanthamoeba Keratitis
by: Lin Chen, et al.
Published: (2022-12-01)

Current Status of Acanthamoeba in Iran: A Narrative Review Article
by: Maryam Niyyati, et al.
Published: (2015-06-01)

Novel Anti-Acanthamoebic Activities of Irosustat and STX140 and Their Nanoformulations
by: Ruqaiyyah Siddiqui, et al.
Published: (2023-03-01)

Successful treatment of multifocal cutaneous leishmaniasis with miltefosine
by: Bhushan Madke, et al.
Published: (2011-01-01)

The Evaluation of Phenolic Acids and Flavonoids Content and Antiprotozoal Activity of <i>Eryngium</i> Species Biomass Produced by Biotechnological Methods
by: Małgorzata Kikowska, et al.
Published: (2022-01-01)

EVALUATION OF MILTEFOSINE AGAINST LEISHMANIA MAJOR (MRHO/IR/75/ER): IN VITRO AND IN VIVO STUDIES
by: J. Esmaeili, et al.
Published: (2008-06-01)

EVALUATION OF MILTEFOSINE AGAINST LEISHMANIA MAJOR (MRHO/IR/75/ER): IN VITRO AND IN VIVO STUDIES
by: J. Esmaeili, et al.
Published: (2008-06-01)

A case report of granulomatous amoebic encephalitis by Group 1 Acanthamoeba genotype T18 diagnosed by the combination of morphological examination and genetic analysis
by: Takahiro Matsui, et al.
Published: (2018-05-01)

AMOEBAE OF THE GENUS ACANTHAMOEBA – PATHOLOGICAL AGENTS IN HUMANS
by: Marcin Padzik, et al.
Published: (2017-04-01)

The role of Src kinase in the biology and pathogenesis of <it>Acanthamoeba castellanii</it>
by: Siddiqui Ruqaiyyah, et al.
Published: (2012-06-01)

Positive kidney profile of dogs with Leishmania sp. and treated with miltefosine
by: Danillo Brenno de Assis Torres, et al.
Published: (2024-03-01)

Effectiveness of miltefosine-pentoxifylline compared to miltefosine in the treatment of cutaneous leishmaniasis in C57Bl/6 mice
by: Ana Angélica Amorim Santarem, et al.
Published: (2014-07-01)

Oral miltefosine treatment in children with visceral leishmaniasis: a brief review
by: Emilio Palumbo

Comparative Study of <i>Plantago media</i> Extracts in the Treatment of <i>Acanthamoeba</i> sp. Trophozoites
by: Anna Budzianowska, et al.
Published: (2023-06-01)

Phytochemical Screening and Acanthamoebic Activity of Shoots from in Vitro Cultures and in Vivo Plants of <i>Eryngium alpinum</i> L.—The Endangered and Protected Species
by: Małgorzata Kikowska, et al.
Published: (2020-03-01)

Pathogenic free-living amoebic encephalitis from 48 cases in China: A systematic review
by: Xiang-Ting Chen, et al.
Published: (2023-02-01)

Molecular Diagnosis of Encephalitis/Meningoencephalitis Caused by Free-Living Amoebae from a Tertiary Center in India
by: Sumeeta Khurana, et al.
Published: (2022-12-01)

Retrospective Long-Term Evaluation of Miltefosine-Allopurinol Treatment in Canine Leishmaniosis
by: Manuela Gizzarelli, et al.
Published: (2023-06-01)

A difficult to treat Leishmania infantum relapse after allogeneic stem cell transplantation
by: Rob J.W. Arts, et al.
Published: (2023-01-01)

Comparing the Effects of Topical Miltefosine and Glucantime in Treatment of Cutaneous Leishmaniasis
by: Ali Asilian, et al.
Published: (2014-03-01)

The in vitro leishmanicidal activity of hexadecylphosphocholine (miltefosine) against four medically relevant Leishmania species of Brazil
by: Eliane de Morais-Teixeira, et al.
Published: (2011-06-01)

Adamantylidene-substituted alkylphosphocholine TCAN26 is more active against Sporothrix schenckii than miltefosine
by: Luana Pereira Borba-Santos, et al.
Published: (2016-01-01)

Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum
by: Isabel M. Vincent, et al.
Published: (2015-10-01)

Etymologia: Acanthamoeba
by: Nitika Pradhan
Published: (2020-08-01)

Anti-Acanthamoeba Effects of Silver and Gold Nanoparticles and Contact Lenses Disinfection Solutions
by: Maryam NIYYATI, et al.
Published: (2018-06-01)

Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis
by: Sankha Koley, et al.
Published: (2013-01-01)

Atypical presentation of an elderly male with autoimmune encephalitis: anti-LG1 limbic encephalitis
by: Binita Bhandari, et al.
Published: (2020-07-01)

Autoimmune Encephalitis—A Multifaceted Pathology
by: Monica Neațu, et al.
Published: (2023-08-01)

Acanthamoeba Infection and Nasal Rinsing, United States, 1994–2022
by: Julia C. Haston, et al.
Published: (2024-04-01)

Structure and Antiparasitic Activity Relationship of Alkylphosphocholine Analogues against <i>Leishmania donovani</i>
by: Humera Ahmed, et al.
Published: (2020-07-01)

In Vitro Susceptibility to Miltefosine of <i>Leishmania infantum</i> (syn. <i>L.</i> <i>chagasi</i>) Isolates from Different Geographical Areas in Brazil
by: Caroline Ricce Espada, et al.
Published: (2021-06-01)

Investigation of in vitro Efficacy of Miltefosine on Chronic Cutaneous Leishmaniasis
by: Varol Tunalı, et al.
Published: (2022-06-01)

Leishmania (Leishmania) amazonenis Infection, Suriname
by: Wendy van der Meide, et al.
Published: (2008-05-01)

Inefficacy of the association N-methyl glucamine and topical miltefosine in the treatment of experimental cutaneous leishmaniasis by Leishmania (Leishmania) amazonensis
by: R. N. R. Sampaio, et al.
Published: (2007-01-01)

Etiology of Encephalitis in Australia, 1990–2007
by: Clare Huppatz, et al.
Published: (2009-09-01)

Japanese spotted fever with post-infectious encephalitis
by: Takafumi Wada, et al.
Published: (2023-01-01)